Status:
COMPLETED
An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
Lead Sponsor:
Graceway Pharmaceuticals, LLC
Conditions:
Warts
Eligibility:
All Genders
3-11 years
Phase:
PHASE2
Brief Summary
The primary purpose of this study is to evaluate the effectiveness in pediatric subjects of three different strengths of resiquimod gel applied to common wart(s) three times a week for up to twelve we...
Eligibility Criteria
Inclusion
- Diagnosis of common wart(s)
- Ages between 3 to 11
Exclusion
- Other types of wart(s), ie. plantar
- Currently participating in another clinical study
- Chronic viral hepatitis B or C
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT00116662
Start Date
March 1 2005
Last Update
February 19 2007
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Arkansas
Fayetteville, Arkansas, United States, 72703
2
Arkansas
Little Rock, Arkansas, United States, 72205
3
Georgia
Newnan, Georgia, United States, 30263
4
Illinois
Buffalo Grove, Illinois, United States, 60089